Schedule 13G ownership disclosure
CLEVELAND BIOLABS INC
Security class unavailable · CUSIP: 185860103
Event date: 2017-04-20
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 1.7700%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001213900-18-002383
- Form type
- SC 13G
- Filer
- ALPHA CAPITAL ANSTALT
- CIK
- CIK 1140358
- Filed
- Feb 28, 2018
- Reporting period
- Apr 20, 2017
- Description
- Schedule 13G beneficial ownership